Thalassemia
Thalassemia known to be an inherited blood disorder which is capable of forming abnormal haemoglobin synthesis. It is suspected to be a genetic disorder inherited by parents, this of two types alpha thalassemia and beta thalassemia this cannot synthesis beta globin, as well thalassemia intermedia which is less severe, the severity depends on no of genes that have been missing Symptoms may vary depending upon the type from mild to severe anaemia, this can lead to tired, pale skin, enlargement of spleen, bone deformities, delayed growth and development and sometimes dark urine in children. Diagnosis include firstly the complete blood count and also genetic tests along with haemoglobin testing. Treatment may vary from the degree of severity and the therapy may include iron chelation, blood transfusions. Iron chelation can be done through deferoxamine, in case of iron overload from transfusions osteoporosis can be a result and spleen become enlarged which needs a surgical removal in emergency.
Initially for detecting the blood disorders bone marrow biopsy will be carried out which involves the study of cytogenetics and surface proteins on bone marrow cells and this study process referred to be flow cytometry. Treating of blood disorder may vary for every particular disorder, this can include use of coagulation factor support, immune modulating therapies, chemotherapy, bone marrow transplantation palliative care must be taken for the patients with complex disorder. Antithrombic are the class of drugs that works in preventing coagulation of blood which can be used in haemodialysis. in preventive measure for life threatening pulmonary emboli cases interventional radiologists implant vena cava filter by the help of ionizing radiation. Generally, through physical examinations, medical reports are used to detect the disorders by physicians to initiate the best therapy.
- Hemochromatosis.
- Idiopathic thrombocytopenic purpura.
- Malaise.
- Bone marrow transplantation.
- Blood transfusion.
Related Conference of Thalassemia
Thalassemia Conference Speakers
Recommended Sessions
- Biomarkers in Hematology.
- Blood based products.
- Blood Disorders Diagnosis and treatment.
- Blood Transfusion
- Genetic Blood Disorders
- Hemato-Oncology
- Hematology
- Hematology & Neurological disorders
- Hematology Nursing
- Hematopathology
- Hemochromatosis
- Immunohematology
- New Drug Discovery in Hematology
- Pediatric Hematology
- Polymerase chain reaction in hematological malignancies.
- Stem Cell Research
- Thalassemia
- Vascular Disorders & Hematology
- Veterinary Hematology
Related Journals
Are you interested in
- Bleeding Disorders in Women - Blood Disorders 2024 (Ireland)
- Digital Health and Artificial Intelligence (AI) in Hematology - Blood Disorders 2024 (Ireland)
- Hematologic Gene Editing and Gene Therapies - Blood Disorders 2024 (Ireland)
- Hematology and Stem Cell Research - Blood Disorders 2024 (Ireland)
- Hematopoietic Stem Cell Transplantation - Blood Disorders 2024 (Ireland)
- Hemoglobinopathies and Sickle Cell Disease - Blood Disorders 2024 (Ireland)
- Hemophilia Management and Research - Blood Disorders 2024 (Ireland)
- Hemostasis and Thrombosis - Blood Disorders 2024 (Ireland)
- Immunotherapy and Hematology - Blood Disorders 2024 (Ireland)
- Leukemia and Lymphoma - Blood Disorders 2024 (Ireland)
- Medicine in Hematology - Blood Disorders 2024 (Ireland)
- Molecular Hematology - Blood Disorders 2024 (Ireland)
- Myelodysplastic Syndromes (MDS) and Bone Marrow Failure - Blood Disorders 2024 (Ireland)
- Next-Generation Diagnostics and Imaging - Blood Disorders 2024 (Ireland)
- Novel Therapies for Blood Cancers - Blood Disorders 2024 (Ireland)
- Pediatric Hematology - Blood Disorders 2024 (Ireland)
- Platelet Disorders - Blood Disorders 2024 (Ireland)
- Sickle Cell Disease (SCD) - Blood Disorders 2024 (Ireland)
- Thalassemia Management - Blood Disorders 2024 (Ireland)
- Transfusion Medicine and Blood Banking - Blood Disorders 2024 (Ireland)